Whole genome sequencing opens door for targeted Waldenstrms therapy
Steven Treon, MD, PhD, of the Dana-Farber Cancer Institute, Boston, MA, outlines the current outlook of Waldenstrms macroglobulinemia (WM), from hand-me-down to targeted approaches. The discovery ...
Author: VJHemOnc
Added: 10/10/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts